MI 4: Zavrimo COVID-19 – Zaviralci DHODH
STATUS MISIJE: REZULTATI V OBDELAVI
NAČRT MISIJE: Domen Oblak in dr. Črtomir Podlipnik
Število tarč: 6
Oznake tarč: 35-40
Število spojin: preko 10 M
Skupaj sidrano 60 M spojin
Trajanje misije: 27.05.2020 –
Rezultati: v obdelavi
Seznam tarč:
#35 4igh – High resolution crystal structure of human dihydroorotate dehydrogenase bound with 4-quinoline carboxylic acid analog
#36 4jtu – Crystal structure of human dihydroorotate dehydrogenase (DHODH) with brequinar analogue
#37 4oqv – High resolution crystal structure of human dihydroorotate dehydrogenase bound with DSM338 (N-[3,5-difluoro-4-(trifluoromethyl)phenyl]-5-methyl-2-(trifluoromethyl)[1,2,4]triazolo[1,5-a]pyrimidin-7-amine)
#38 3i65 – Plasmodium falciparum dihydroorotate dehydrogenase bound with triazolopyrimidine-based inhibitor DSM1
#39 4cq8 – Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) in complex with Genz-669178
#40 4rx0 – Crystal structure of Plasmodium falciparum dihydroorotate dehydrogenase bound with Inhibitor DSM265
OPIS MISIJE:
REFERENCE:
Xiong R, Zhang L, Li S, et al. Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2. bioRxiv; 2020. DOI: 10.1101/2020.03.11.983056.